Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (651-660 of 4,679) with videos related to

Pageof 468
Sort By:
Cancer Discovery|May 13, 2016
Targeting Macrophages Boosts Pancreatic Cancer Therapy
Cancer Discovery|May 15, 2016
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed PhenotypeDaniela Bossi, Angelo Cicalese, Gaetano I Dellino, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.
Cancer Discovery|June 15, 2016
New Driver Mutations Detected in NSCLC
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cancer Discovery|April 30, 2016
Chemotherapy Efficacy Is Dependent upon p53 Dynamics
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
Cancer Discovery|June 9, 2016
FDA Approves Drug Combo for Kidney Cancer
Cancer Discovery|November 18, 2017
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor VenetoclaxJoel D Leverson, Deepak Sampath, Andrew J Souers, et al.
Pageof 468

Showing results (651-660 of 4,679) with videos related to

Sort By:
Pageof 468
Cancer Discovery|May 13, 2016
Targeting Macrophages Boosts Pancreatic Cancer Therapy
Cancer Discovery|May 15, 2016
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed PhenotypeDaniela Bossi, Angelo Cicalese, Gaetano I Dellino, et al.
Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.
Cancer Discovery|June 15, 2016
New Driver Mutations Detected in NSCLC
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cancer Discovery|April 30, 2016
Chemotherapy Efficacy Is Dependent upon p53 Dynamics
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
Cancer Discovery|June 9, 2016
FDA Approves Drug Combo for Kidney Cancer
Cancer Discovery|November 18, 2017
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor VenetoclaxJoel D Leverson, Deepak Sampath, Andrew J Souers, et al.
Pageof 468